Natalizumab plus interferon-β-1a more efficacious in MS

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1528, 2006-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-β-1a and interferon-β-1b have comparable efficacy in MS

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Early interferon-β-1b of BENEFIT for MS?

By  

Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Interferon-β1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β-1a: Pancreatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1424, 2012-01 ,pp. : 32-33

Adis International

Access to resources Recommend Favorite

Subcutaneous Interferon-β-1a: New Formulation

By McKeage Kate   Wagstaff Antona J.  

CNS Drugs, Vol. 21, Iss. 10, 2007-01 ,pp. : 871-876

Adis International

Access to resources Recommend Favorite